Insufficient scRNA-seq data for expression of INSL5 at single-cell level.
Insufficient scRNA-seq data for expression of INSL5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 83% | 8.12 | 2199 / 2642 | 11% | 0.20 | 75 / 705 |
prostate | 63% | 4.33 | 154 / 245 | 24% | 1.95 | 121 / 502 |
kidney | 80% | 6.04 | 71 / 89 | 3% | 0.05 | 24 / 901 |
thymus | 77% | 4.39 | 500 / 653 | 0% | 0.01 | 3 / 605 |
intestine | 57% | 54.95 | 551 / 966 | 19% | 3.56 | 100 / 527 |
lung | 46% | 2.02 | 265 / 578 | 0% | 0.00 | 2 / 1155 |
uterus | 39% | 1.51 | 66 / 170 | 5% | 0.40 | 22 / 459 |
adrenal gland | 41% | 1.55 | 107 / 258 | 1% | 0.01 | 2 / 230 |
breast | 37% | 1.40 | 168 / 459 | 2% | 0.02 | 17 / 1118 |
spleen | 38% | 1.12 | 91 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 37% | 1.70 | 491 / 1335 | 0% | 0 | 0 / 0 |
ovary | 35% | 1.11 | 63 / 180 | 1% | 0.04 | 3 / 430 |
stomach | 16% | 0.43 | 56 / 359 | 14% | 1.19 | 39 / 286 |
pancreas | 25% | 0.74 | 83 / 328 | 2% | 0.09 | 3 / 178 |
heart | 27% | 0.79 | 231 / 861 | 0% | 0 | 0 / 0 |
bladder | 19% | 0.95 | 4 / 21 | 6% | 0.75 | 32 / 504 |
adipose | 22% | 0.69 | 262 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 20% | 0.57 | 292 / 1445 | 1% | 0.01 | 1 / 183 |
skin | 18% | 0.53 | 328 / 1809 | 0% | 0.01 | 2 / 472 |
liver | 14% | 0.31 | 31 / 226 | 0% | 0.01 | 2 / 406 |
muscle | 7% | 0.19 | 57 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 4% | 0.10 | 38 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_2000253 | Biological process | positive regulation of feeding behavior |
GO_0008150 | Biological process | biological_process |
GO_0005575 | Cellular component | cellular_component |
GO_0005576 | Cellular component | extracellular region |
GO_0005179 | Molecular function | hormone activity |
GO_0005515 | Molecular function | protein binding |
GO_0001664 | Molecular function | G protein-coupled receptor binding |
Gene name | INSL5 |
Protein name | Insulin-like peptide INSL5 (Insulin-like peptide 5) [Cleaved into: Insulin-like peptide INSL5 B chain; Insulin-like peptide INSL5 A chain] |
Synonyms | UNQ156/PRO182 |
Description | FUNCTION: May have a role in gut contractility or in thymic development and regulation. Activates RXFP4 with high potency and appears to be the endogenous ligand for this receptor. |
Accessions | Q9Y5Q6 ENST00000304526.3 |